Intercept Pharmaceuticals, Inc. (ICPT): Rumor News

ICPT – Speculation of weaker prescription data.


Key Facts Surrounding This News Item


  • ICPT had a POWR Rating of D (Sell) coming into today.
  • ICPT was 17.14% above its 10-Day Moving Average coming into today.
  • ICPT was -8.27% below its 20-Day Moving Average coming into today.
  • ICPT was -25.92% below its 50-Day Moving Average coming into today.
  • ICPT was -33.81% below its 100-Day Moving Average coming into today.
  • ICPT was -35.16% below its 200-Day Moving Average coming into today.
  • ICPT had returned -33.03% year-to-date leading up to today’s news, versus a +15.55% return from the benchmark S&P 500 during the same period.

More Info About Intercept Pharmaceuticals, Inc. (ICPT)


Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases. The company was founded in 2002 and is based in New York, New York. View our full ICPT ticker page with ratings, news, and more.

ICPT at a Glance

ICPT Current POWR Rating™
Overall POWR Rating™
ICPT Current Price $67.06 0.46%
More ICPT Ratings, Data, and News

ICPT Price Reaction

The day of this event (Oct. 6, 2017)
ICPT Closing Price$69.92 3.91%
ICPT Volume4,262,400
536.51% from avg
Leading up to this event
ICPT 1-mo return38.13%
After this event
ICPT 1-day return5.16%
ICPT 3-day return7.68%
ICPT 5-day return11.10%

ICPT Price Chart



More Intercept Pharmaceuticals, Inc. (ICPT) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ICPT News
Page generated in 0.6224 seconds.